However, it is KRAS that has the highest mutation incidence in pancreatic cancer—twice its occurrence in cancer of the colon or small intestine, followed in decreasing order by endometrium and lung cancers and much lower in neoplasms of other tissues. Here, KRAS is linked to pancreatic neoplasm.